Protocol Ledger

NCT03710642 · Phase II · COMPLETED

Prazosin for Agitation in Alzheimer's Disease

Interventional Phase II clinical trial protocol NCT03710642 sponsored by Alzheimer's Disease Cooperative Study (ADCS) in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-10-23 Enrollment: 35 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03710642
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)35 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03710642
Protocol FieldVerified Registry Value
NCT IdentifierNCT03710642
Consolidated Lead SponsorAlzheimer's Disease Cooperative Study (ADCS)
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment35 participants (ACTUAL)
Registered Start Date2018-10-23
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI